0000805928-23-000009.txt : 20230201 0000805928-23-000009.hdr.sgml : 20230201 20230201184529 ACCESSION NUMBER: 0000805928-23-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230130 FILED AS OF DATE: 20230201 DATE AS OF CHANGE: 20230201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARIANI PETER J CENTRAL INDEX KEY: 0001222357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36046 FILM NUMBER: 23578234 MAIL ADDRESS: STREET 1: C/O GUIDANT CORP STREET 2: 111 MONUMENT CIRCLE #2900 CITY: INDIANAPOLIS STATE: IN ZIP: 46204-5129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axogen, Inc. CENTRAL INDEX KEY: 0000805928 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411301878 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: (386) 462-6817 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 FORMER COMPANY: FORMER CONFORMED NAME: AxoGen, Inc. DATE OF NAME CHANGE: 20111004 FORMER COMPANY: FORMER CONFORMED NAME: LECTEC CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 wf-form4_167529511485643.xml FORM 4 X0306 4 2023-01-30 0 0000805928 Axogen, Inc. AXGN 0001222357 MARIANI PETER J 111 W OAK AVE. SUITE 500 TAMPA FL 33602 0 1 0 0 EVP & Chief Financial Officer Common Stock 2023-01-30 4 M 0 20939 5.04 A 63047 D Common Stock 2023-01-30 4 S 0 14111 9.69 D 48936 D Common Stock 2023-01-31 4 M 0 20939 5.04 A 69875 D Common Stock 2023-01-31 4 S 0 14320 9.55 D 55555 D Common Stock 2023-02-01 4 M 0 20940 5.04 A 76495 D Common Stock 2023-02-01 4 S 0 14550 9.36 D 61945 D Employee Stock Option (right to purchase) 5.04 2023-01-30 4 M 0 20939 0 D 2020-03-01 2023-03-01 Common Stock 20939.0 41879 D Employee Stock Option (right to purchase) 5.04 2023-01-31 4 M 0 20939 0 D 2020-03-01 2023-03-01 Common Stock 20939.0 20940 D Employee Stock Option (right to purchase) 5.04 2023-02-01 4 M 0 20940 0 D 2020-03-01 2023-03-01 Common Stock 20940.0 0 D The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, in order to exercise options that are scheduled to expire on March 1, 2023. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.36 to $9.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.20 to $9.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. All shares of Common Stock underlying the employee stock option were fully vested on March 1, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 1, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. /s/Peter Mariani 2023-02-01